| |
| |
|
| Insider
Information: |
Levy Richard S |
| Relationship: |
|
| City: |
Wilmington |
| State: |
DE |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
67,748 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$3,727,864 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
67,748 |
|
|
| Total
Value |
$3,727,864 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
0
|
|
Stock
price went up :
|
1
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
1.0
|
0.0
|
| Percentage
Gain/Loss : |
 195.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Incyte Corp |
INCY |
EVP, Chief Drug Dev Of... |
2016-01-06 |
16,926 |
2010-03-15 |
0 |
Premium* |
|
|
Madrigal Pharmaceuticals Inc |
MDGL |
|
2024-04-01 |
10,298 |
2017-08-21 |
0 |
Premium* |
|
|
Protara Therapeutics, Inc |
TARA |
Director |
2020-01-10 |
31,000 |
2020-01-10 |
0 |
Premium* |
|
|
Kodiak Sciences Inc. |
KOD |
Director |
2020-03-20 |
1,000 |
2020-03-20 |
0 |
Premium* |
|
|
Kiniksa Pharmaceuticals, Ltd. |
KNSA |
|
2024-05-03 |
8,524 |
2023-06-29 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
81 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 4 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| INCY |
Incyte Corp |
EVP, Chief Drug Dev Officer |
• – – |
2015-07-15 |
4 |
AS |
$120.00 |
$8,426,040 |
D/D |
(70,217) |
21,227 |
0 |
- |
|
| INCY |
Incyte Corp |
EVP, Chief Drug Dev Officer |
• – – |
2015-07-15 |
4 |
OE |
$17.79 |
$1,249,160 |
D/D |
70,217 |
91,444 |
0 |
- |
|
| INCY |
Incyte Corp |
EVP, Chief Drug Dev&Medical Of |
• – – |
2013-02-15 |
4 |
OE |
$5.46 |
$673,176 |
D/D |
98,440 |
98,440 |
0 |
- |
|
| INCY |
Incyte Corp |
EVP, Chief Drug Dev&Medical Of |
• – – |
2013-02-15 |
4 |
S |
$22.48 |
$2,212,931 |
D/D |
(98,440) |
0 |
0 |
- |
|
| INCY |
Incyte Corp |
EVP, Chief Drug Dev&Medical Of |
• – – |
2014-02-13 |
4 |
OE |
$3.11 |
$1,595,213 |
D/D |
191,309 |
195,610 |
0 |
- |
|
| INCY |
Incyte Corp |
EVP, Chief Drug Dev&Medical Of |
• – – |
2014-02-13 |
4 |
S |
$66.38 |
$12,699,091 |
D/D |
(191,309) |
4,301 |
0 |
- |
|
81 Records found
|
|
Page 4 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
